Independent GLP-1 research, comparisons and global market intelligenceExplore the platform →
HOW THE RESEARCH WORKS

See how regulators, peer-reviewed studies, clinical trials, official labels and verified market sources are evaluated.

Evidence and Verification

GLP1Scientist Research Methodology

A transparent framework for defining research questions, selecting sources, separating evidence types, recording context and communicating uncertainty.

Illustration representing evidence interpretation

Research principles

From a defined question to a defensible answer

GLP1Scientist uses a structured research process to identify appropriate sources, compare evidence, preserve context, communicate uncertainty and update time-sensitive information.

Core objective: explain not only what a source reports, but also the jurisdiction, population, formulation, study design, duration and limitations behind the claim.

Evidence process

Discover, compare and understand

Illustration representing research discovery

1. Discover

Define the question and identify the strongest authoritative sources capable of answering it.

Illustration representing evidence comparison

2. Compare

Compare dates, jurisdictions, populations, formulations, outcomes and evidence strength.

Illustration representing evidence interpretation

3. Understand

Interpret what the evidence supports, what it does not support and what remains unresolved.

Source hierarchy

Preferred order of evidence

1. Regulators and approved information

Approval documents, authorised labels, safety communications and official product information.

2. Peer-reviewed research

Clinical studies, systematic reviews and meta-analyses.

3. Trial registries

Study design, status, sponsor, endpoints and submitted results, interpreted with appropriate caution.

4. Government and medical institutions

Official health agencies and recognized medical institutions.

5. Manufacturers and filings

Official product materials, company disclosures, patent records and corporate filings.

6. Industry and media

Transparent commercial, financial and established media sources where stronger evidence is unavailable.

Evidence categories

Facts, findings and analysis remain distinct

Regulatory fact

Information confirmed by a regulator, approval document or authorised label.

Study finding

A result reported in clinical or observational research.

Trial-registry information

Submitted study design, status, sponsor and results information.

Manufacturer-reported information

Product, pipeline or company information supplied by the manufacturer.

Market or patent information

Pricing, access, patent, company or competitive information.

GLP1Scientist analysis

Interpretation, comparison, synthesis or inference based on identified sources.

Uncertainty and updates

Limitations stay visible

Pages identify when evidence is preliminary, indirect, jurisdiction-specific, early-stage, based on short follow-up or missing direct comparison. Trial averages are not presented as personal forecasts.

  • Publication and last-reviewed dates
  • Relevant regulator or database checked
  • Source-access dates
  • Material changes and whether conclusions changed